Email Us Here

[Pangyo Bio & Medical] SK Bioscience Agrees to Extend Contract Production of Global COVID-19 Vaccine Until the End of 2022

SK Bioscience and CEPI finally reached an agreement to extend the Andong L House facility use contract until the end of 2022.